期刊文献+

曲古菌素A对血管平滑肌细胞p27kip1表达的调控机制研究 被引量:1

Effect of Trichostatin A on p27kip1 Expression in Vascular Smooth Muscle Cells
下载PDF
导出
摘要 目的探讨组蛋白去乙酰化酶抑制剂曲古菌素A(Trichostatin A,TSA)对血管平滑肌细胞(VSMC)的p27kip1表达的影响和调控机制。方法半定量逆转录聚合酶链反应(RT-PCR)检测p27kip1的mRNA水平,蛋白印迹测定p27kip1和S-phase kinase-associated protein-2(skp2)蛋白表达,荧光分光光度法测定20S蛋白酶体活性。结果100 ng/ml TSA不影响VSMC中p27kip1的mRNA水平。100 ng/mlTSA显著抑制血清诱导的p27kip1蛋白下调,并延长p27kip1蛋白的半衰期。100 ng/ mlTSA抑制血清诱导的skp2表达上调,且skp2表达与相应时点p27kip1蛋白呈负相关。100 ng/ml TSA对20S蛋白酶体活性物影响。结论TSA对VSMC的p27kip1表达调控不是在转录水平上,而是通过翻译后机制抑制血清诱导VSMC的p27kip1蛋白降解,其机制可能与TSA抑制泛素连接酶亚单位skp2表达有关。 Objective To investigate the effect of Trichostatin A (TSA) on p27kip1 gene expression in vascular smooth muscle ceils. Methods Reverse Transcription-Polymerase Chain Reaction was used to measure the level of p27kip1 mRNA. The levels of p27kip1 and S-phase kinase-associated protein-2 ( skp2 ) protein were determined by western blotting. 20S proteasome activity was quantified by using a fluorogenic proteasome-specific substrate. Results TSA did not affect mRNA level of p27kip1 in VSMC, but attenuated serum-induced downregulation of p27kip1 through stabilizing p27kip1 turnover. In addition, TSA potently decreased the expression of skp2, an F-box protein that targets p27kip1 for degradation, but had no effect on protease activity. Conclusion TSA regulate p27kip1 expression at the post-translational level in VSMC.
出处 《中国分子心脏病学杂志》 CAS 2007年第2期92-95,共4页 Molecular Cardiology of China
关键词 曲古菌素A 血管平滑肌细胞 P27KIP1 S—phase kinase—associated protein-2 Trichostatin A Vascular smooth muscle cell p27kip1 S-phase kinase-associated protein-2
  • 相关文献

参考文献10

  • 1[1]Drummond DC,Noble CO,Kirpotin DB,et al.Clinical development of histone deacetylase inhibitors as anticancer agents.Annu Rev Pharmacol Toxicol,2005,45:495-528.
  • 2[2]Okamoto H,Fujioka Y,Takahashi A,et al.Trichostatin A,an inhibitor of histone deacetylase,inhibits smooth muscle cell proliferation via induction of p21 (WAF1).J Atheroscler Thromb,2006,13(4):183-191.
  • 3[3]Gartel AL,Tyner AL.Transcriptional regulation of the p21 (WAF1/CIP1) gene.Exp Cell Res,1999,246 (2):280-289.
  • 4[4]Sowa Y,Orita T,Hiranabe-Minamikawa S,et al.Histone deacetylase inhibitor activates the p21/WAF1/Cipl gene promoter through the Spl sites.Ann N Y Acad Sci,1999,886:195-199.
  • 5[5]Blain SW,Scher HI,Cordon-Cardo C,et al.p27 as a target for cancer therapeutics.Cancer Cell,2003,3 (2):111-115.
  • 6[6]Mani A,Gelmann EP.The ubiquitin-proteasome pathway and its role in cancer.J Clin Oncol,2005,23(21):4776-4789.
  • 7[7]Place RF,Noonan EJ,Giardina C.HDACs and the senescent phenotype of WI-38 cells.BMC Cell Biology,2005,6:37-48.
  • 8[8]Yin L,Laevsky G,Giardina C.Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity.J Biol Chem,2001,276(48):44641-44646.
  • 9[9]Kaiser M,Zavrski I,Sterz J,et al.The effects of the histone deacetylase inhibitor valproic acid on cell cycle,growth suppression and apoptosis in multiple myeloma.Haematologica,2006,91 (2):248-251.
  • 10[10]Wu YJ,Bond M,Sala-Newby GB,et al.Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation.Circ Res,2006,98(9):1141-1150.

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部